Monday, 26 October 2026European Markets

SOCIETE GENERALE And 3 Other Stocks Have Very High Payout Ratio

Loading stream...

(vianews) - societe generale (gle.pa), rubis (rui.pa), voss veksel ogland (vvl.ol) are the highest payout ratio stocks on this list.

here's the data we've collected of stocks with a high payout ratio at the moment. the payout ratio in itself isn't a promise of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.

when researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. societe generale (gle.pa)

95.38% payout ratio

société générale société anonyme provides banking and financial services to individuals, businesses, and institutional investors in europe and internationally. it operates through french retail banking, international retail banking & financial services, and global banking and investor solutions. it offers retail banking services, such as consumer credit, vehicle leasing and fleet management, online banking, wealth management services, and equipment and vendor finance under the societe generale, credit du nord, and boursorama brand names; and insurance products, including home, vehicle, family, health, and mortgage insurance. the company also provides corporate and investment banking, securities, business consulting, consumer finance, advisory and financing, and asset management and private banking services. in addition, it offers brokerage, cash management, payment, factoring, export financing, and supply chain financing services. société générale société anonyme was incorporated in 1864 and is headquartered in paris, france.

earnings per share

as for profitability, societe generale has a trailing twelve months eps of €1.73.

pe ratio

societe generale has a trailing twelve months price to earnings ratio of 12.36. meaning, the purchaser of the share is investing €12.36 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.1%.

more news about societe generale.

2. rubis (rui.pa)

58.49% payout ratio

rubis engages in the operation of bulk liquid storage facilities for commercial and industrial customers in europe, africa, and the caribbean. the company operates through retail & marketing, support & services, and renewable electricity production segments. it operates terminals that provide bulk liquid storage facilities for fuels, chemicals, and agri-food products; and distributes fuels, liquefied gases, bitumen, and lubricants. the company also provides infrastructure, transportation, supply, and services for supporting the development of downstream distribution and marketing activities; and produces photovoltaic electricity. rubis was incorporated in 1954 and is headquartered in paris, france.

earnings per share

as for profitability, rubis has a trailing twelve months eps of €2.49.

pe ratio

rubis has a trailing twelve months price to earnings ratio of 10.46. meaning, the purchaser of the share is investing €10.46 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.72%.

more news about rubis.

3. voss veksel ogland (vvl.ol)

45.23% payout ratio

voss veksel- og landmandsbank asa provides banking products and services to private individuals and companies in norway. the company offers saving accounts; car and other vehicle, home, small, and construction loans; overdrafts facilities; leasing services; bank guarantees; bank and payment cards; insurance products; and online and mobile banking services. the company was founded in 1843 and is based in voss, norway.

earnings per share

as for profitability, voss veksel ogland has a trailing twelve months eps of kr22.81.

pe ratio

voss veksel ogland has a trailing twelve months price to earnings ratio of 10.43. meaning, the purchaser of the share is investing kr10.43 for every norwegian krone of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.24%.

volume

today's last reported volume for voss veksel ogland is 2 which is 99.51% below its average volume of 412.

more news about voss veksel ogland.

4. ald (ald.pa)

38.71% payout ratio

ald s.a. provides service leasing and vehicle fleet management services. its products and services include full service leasing, fleet management, outsourcing solutions, and sale and lease back; fleet consultancy; and tools and services for fleet managers and drivers. the company is also involved in trading used cars and light commercial vehicles, and the retail sale of vehicles. the company operates in western europe, central and eastern europe, northern europe, south america, africa, and asia. ald s.a. was founded in 1946 and is based in rueil-malmaison, france. ald s.a. operates as a subsidiary of société générale société anonyme.

earnings per share

as for profitability, ald has a trailing twelve months eps of €2.68.

pe ratio

ald has a trailing twelve months price to earnings ratio of 4.01. meaning, the purchaser of the share is investing €4.01 for every euro of annual earnings.

yearly top and bottom value

ald's stock is valued at €10.75 at 12:10 est, way below its 52-week high of €14.30 and way above its 52-week low of €9.18.

more news about ald.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com